Literature DB >> 11536400

MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.

K Turetschek1, E Floyd, T Helbich, T P Roberts, D M Shames, M F Wendland, W O Carter, R C Brasch.   

Abstract

A new contrast medium, MS-325, was compared to albumin-(Gd-DTPA)(30) in 18 chemically induced rat breast tumors based on quantitative estimates of microvascular permeability (K(PS)) and fractional plasma volume (fPV) using a two-compartment bidirectional model. No significant correlation was found between MS-325-enhanced microvascular assays with either tumor grade or with microvascular counts (MVCs). In comparison, the correlation coefficient between K(PS) and histologic tumor grade using albumin-(Gd-DTPA)(30) (r =.58) was statistically significant (P <.01). Also, using albumin-(Gd-DTPA)(30), a significant correlation (r =.55, P <.05) was observed between the K(PS) and MVC, a biomarker of angiogenesis. Correlations between fPV and MVC were not statistically significant for either contrast medium. In conclusion, using MS-325, no significant correlations between the MR-estimated permeability values or plasma volumes were observed in experimental breast tumors with either the histologic tumor grade or MVC. This analysis confirms our previous determination that capillary permeability estimates, using a prototype large molecular contrast medium, albumin-(Gd-DTPA)(30), correlate significantly with both histologic tumor grade and MVC. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536400     DOI: 10.1002/jmri.1179

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  18 in total

1.  Non-invasive MR assessment of macroscopic and microscopic vascular abnormalities in the rectal tumour-surrounding mesorectum.

Authors:  Ewelina Kluza; Jean-Paul J E Kleijnen; Milou H Martens; Dorit Rennspiess; Monique Maas; Cécile R L P N Jeukens; Robert G Riedl; Axel zur Hausen; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

2.  Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.

Authors:  Federico Boschi; Pasquina Marzola; Marco Sandri; Elena Nicolato; Mirco Galiè; Silvia Fiorini; Flavia Merigo; Vito Lorusso; Linda Chaabane; Andrea Sbarbati
Journal:  MAGMA       Date:  2008-03-04       Impact factor: 2.310

Review 3.  Preclinical imaging: an essential ally in modern biosciences.

Authors:  Lídia Cunha; Ildiko Horvath; Sara Ferreira; Joana Lemos; Pedro Costa; Domingos Vieira; Dániel S Veres; Krisztián Szigeti; Teresa Summavielle; Domokos Máthé; Luís F Metello
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

4.  Multi-slice DCE-MRI data using P760 distinguishes between metastatic and non-metastatic rodent prostate tumors.

Authors:  Xiaobing Fan; Milica Medved; Sean Foxley; Jonathan N River; Marta Zamora; Gregory S Karczmar; Claire Corot; Philippe Robert; Philippe Bourrinet
Journal:  MAGMA       Date:  2006-01-17       Impact factor: 2.310

Review 5.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

6.  [Preclinical imaging in animal models of radiation therapy].

Authors:  K Nikolaou; C C Cyran; K Lauber; M F Reiser; D-A Clevert
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

7.  Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.

Authors:  Louke J Delrue; Veerle Casneuf; Nancy Van Damme; Peter Blanckaert; Marc Peeters; Wim P Ceelen; Philippe C O Duyck
Journal:  MAGMA       Date:  2011-05-13       Impact factor: 2.310

8.  HiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomography.

Authors:  Chad R Haney; Charles A Pelizzari; Sean Foxley; Marta A Zamora; Devkumar Mustafi; Maria Tretiakova; Shihong Li; Xiaobing Fan; Gregory S Karczmar
Journal:  Mol Imaging       Date:  2011-03-01       Impact factor: 4.488

9.  Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas.

Authors:  A Preda; P A Wielopolski; T L M Ten Hagen; M van Vliet; J F Veenland; G Ambagtsheer; S T van Tiel; M W Vogel; A M M Eggermont; G P Krestin; C F van Dijke
Journal:  MAGMA       Date:  2004-10-10       Impact factor: 2.310

10.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.